BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14997382)

  • 1. Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma.
    Imai MA; Oda Y; Oda M; Nakanishi I; Kawahara E
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):320-6. PubMed ID: 14997382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
    Eymin B; Gazzeri S; Brambilla C; Brambilla E
    Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers.
    Onda M; Nagai H; Yoshida A; Miyamoto S; Asaka SI; Akaishi J; Takatsu K; Nagahama M; Ito K; Shimizu K; Emi M
    J Hum Genet; 2004; 49(6):312-318. PubMed ID: 15118916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
    Tedesco D; Vesco C
    Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
    Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.
    Karakaidos P; Taraviras S; Vassiliou LV; Zacharatos P; Kastrinakis NG; Kougiou D; Kouloukoussa M; Nishitani H; Papavassiliou AG; Lygerou Z; Gorgoulis VG
    Am J Pathol; 2004 Oct; 165(4):1351-65. PubMed ID: 15466399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotype of Hurthle and Warthin-like papillary thyroid carcinomas is distinct from classic papillary carcinoma as to the expression of retinoblastoma protein and E2F-1 transcription factor.
    Anwar F
    Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):20-7. PubMed ID: 12610352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels and activity of E2F1 transcription factor in myelodysplastic bone marrow.
    Saberwal G; Lucas S; Janssen I; Deobhakta A; Hu WY; Galili N; Raza A; Mundle SD
    Int J Hematol; 2004 Aug; 80(2):146-54. PubMed ID: 15481443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of E2F-1 and Rb expression with papillomatosis and ductal carcinoma in situ of the breast].
    Niu Y; Li Y; Niu RF; Lü AJ; Fu XL
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):290-3. PubMed ID: 15312366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas.
    Gorgoulis VG; Zacharatos P; Mariatos G; Kotsinas A; Bouda M; Kletsas D; Asimacopoulos PJ; Agnantis N; Kittas C; Papavassiliou AG
    J Pathol; 2002 Oct; 198(2):142-56. PubMed ID: 12237873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
    J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
    Pietruszewska W; Klatka J; Borzecki A; Rieske P
    Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma.
    Volm M; Koomägi R; Rittgen W
    Int J Cancer; 1998 Jun; 79(3):294-9. PubMed ID: 9645354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.